Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2003 Mar 1;94(2):127–129. doi: 10.1007/BF03404585

Hepatitis C Update

Shimian Zou 1,✉, Leslie Forrester 1, Antonio Giulivi 1
PMCID: PMC6979800  PMID: 12675169

The content is available as a PDF (97.0 KB).

References

  • 1.Can J Public Health. 2000.
  • 2.Zou S, Tepper ML, Giulivi A. Hepatitis C in Canada. Can Commun Dis Rep. 2001;27(S3):13–15. [Google Scholar]
  • 3.Sattar SA, Tetro J, Springthorne VS, Giulivi A. Preventing the spread of hepatitis B and C viruses: Where are germicides relevant? Am J Infect Control. 2001;29:187–97. doi: 10.1067/mic.2001.114233. [DOI] [PubMed] [Google Scholar]
  • 4.Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, Rinfret A e al. Nat Med. 2001. Hepatitis C virus replication in mice with chimeric human livers; pp. 927–33. [DOI] [PubMed] [Google Scholar]
  • 5.Bartenschlager R, Lohmann V. Novel cell culture systems for the hepatitis C virus. Antiviral Res. 2001;52(1):1–17. doi: 10.1016/S0166-3542(01)00164-4. [DOI] [PubMed] [Google Scholar]
  • 6.Korenaga M, Hino K, Katoh Y, Yamaguchi Y, Okuda M, Yoshioka K, Okita K. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J Viral Hepat. 2001;8(5):331–40. doi: 10.1046/j.1365-2893.2001.00305.x. [DOI] [PubMed] [Google Scholar]
  • 7.Barrett S, Goh J, Coughlan B, Ryan E, Stewart S, Cockram A e al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: Spontaneous viral clearance and chronic HCV infection. Gut. 2001;49:423–30. doi: 10.1136/gut.49.3.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A e al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999;341:866–70. doi: 10.1056/NEJM199909163411202. [DOI] [PubMed] [Google Scholar]
  • 9.Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N e al. The natural history of hepatitis C virus infection: Host, viral and environmental factors. JAMA. 2000;26(4):450–56. doi: 10.1001/jama.284.4.450. [DOI] [PubMed] [Google Scholar]
  • 10.Yeo AET, Ghany M, Conry-Cantilena C, Melpolder JC, Kleiner DE, Shih J e al. Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatical chronic hepatitis C virus carriers. J Viral Hepatitis. 2001;8:256–63. doi: 10.1046/j.1365-2893.2001.00302.x. [DOI] [PubMed] [Google Scholar]
  • 11.Adinolfi LE, Utili R, Andreana A, Tripodi MF, Marracino M, Gambardella M e al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci. 2001;46(8):1677–83. doi: 10.1023/A:1010697319589. [DOI] [PubMed] [Google Scholar]
  • 12.Myers RP, Hilsden RJ, Lee SS. J Viral Hepat. 2001. Historical features are poor indicators of liver fibrosis in Canadian patients with chronic hepatitis C; pp. 249–55. [DOI] [PubMed] [Google Scholar]
  • 13.Health Canada. Notifiable Disease Annual Summary. Can Commun Dis Rep. 2000;26(S5):59. [PubMed] [Google Scholar]
  • 14.Health Canada. Notifiable Disease Annual Summary. Can Commun Dis Rep. 2001;27(S6):55. [PubMed] [Google Scholar]
  • 15.Zou S, Zhang J, Tepper M, Giulivi A, Baptiste B, Predy G e al. Enhanced surveillance of acute hepatitis B and acute hepatitis C in four health regions in Canada. Can J Infect Dis. 2001;12(6):357–63. doi: 10.1155/2001/719650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Forrester L, Shi Y, Stoodley G, Zou S, Giulivi A, Poliquin D, et, al. Enhanced surveillance of acute hepatitis B and acute hepatitis C in Canada. National Conference for Viral Hepatitis Coordinators 2001, Virginia, US.
  • 17.Forrester L, Shi Y, Stoodley G, Zou S, Giulivi A, Poliquin D, et, al. Incidence of acute hepatitis C in the Canadian Aboriginal population, 1999–2000. National Conference for Viral Hepatitis Coordinators 2001, Virginia, US.
  • 18.Zou S, ElSaadany S, Forrester L, Giulivi A. Am J Epidemiol. 2001. Estimating the incidence of new hepatitis C virus infection in Canada; p. S214. [Google Scholar]
  • 19.Remis R, Hogg R, Krahn MD, Preiksaitis JK, Sherman M. Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960–85 and 1990–92. 1998. [Google Scholar]
  • 20.Pohani G, Zou S, Tepper M. Trends of hepatitis B and hepatitis C mortality in Canada, 1979–1997. Can J Public Health. 2001;92(4):250–54. doi: 10.1007/BF03404954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zou S, Tepper ML, ElSaadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol. 2000;14:575–80. doi: 10.1155/2000/642707. [DOI] [PubMed] [Google Scholar]
  • 22.Green ST, Mohsen AH, McKendrick MW, Dawes Y, Prakasam SF, Walberg R, Schmid ML. Potential for hepatitis C transmission among non-needle/syringe sharing Sheffield drug injectors through the sharing of drug preparation paraphernalia. Commun Dis Public Health. 2001;4(1):38–41. [PubMed] [Google Scholar]
  • 23.Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ. 2001;65(5):557–60. [PMC free article] [PubMed] [Google Scholar]
  • 24.Yeung LTF, King SM, Roberts EA. Mother-toinfant transmission of hepatitis C virus. Hepatology. 2001;34(2):223–29. doi: 10.1053/jhep.2001.25885. [DOI] [PubMed] [Google Scholar]
  • 25.Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder L e al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887–91. doi: 10.1016/S0140-6736(99)06527-7. [DOI] [PubMed] [Google Scholar]
  • 26.Trasancos CC, Kainer MA, Desmond PV, Kelly H. Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia. Aust N Z J Public Health. 2001;25(3):241–44. doi: 10.1111/j.1467-842X.2001.tb00569.x. [DOI] [PubMed] [Google Scholar]
  • 27.Yerly S, Quadri R, Negro F, Barbe KP, Cheseaux JJ, Burgisser P e al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis. 2001;84(3):369–72. doi: 10.1086/322036. [DOI] [PubMed] [Google Scholar]
  • 28.Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, Lin SH. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors. J Med Virol. 2001;65(1):30–34. doi: 10.1002/jmv.1097. [DOI] [PubMed] [Google Scholar]
  • 29.Health Canada. Hepatitis C — Prevention and Control: A Public Health Consensus. Can Commun Dis Rep. 1999;25(S2):1–25. [PubMed] [Google Scholar]
  • 30.Sakai N, Tatsuta M, Iishi H, Yano H, Osaka S, Aoki A. Effectiveness of manual cleaning and disinfection of gastroendoscopes with 3% glutaraldehyde for decreasing risk of transmission of hepatitis C virus. Am J Gastroenterol. 2001;96(6):1803–6. doi: 10.1111/j.1572-0241.2001.03796.x. [DOI] [PubMed] [Google Scholar]
  • 31.Brinster C, Inchauspe G. DNA vaccines for hepatitis C virus. Intervirology. 2001;44(2–3):143–53. doi: 10.1159/000050041. [DOI] [PubMed] [Google Scholar]
  • 32.Leonard L, Navarro C, Pelude L, Forrester L. The effectiveness of harm reduction strategies in modifying hepatitis C infection among injection drug users in Canada. Can Commun Dis Rep. 2001;27(S3):52–55. [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES